A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh

Fahima Chowdhury, Khalid Ali Syed, Afroza Akter, Taufiqur Rahman Bhuiyan, Imam Tauheed, Fatema Khaton, Rajib Biswas, Jannatul Ferdous, Hasan Al Banna, Allen G. Ross, Nigel Mc Millan, Tarun Sharma, Vibhu Kanchan, Ajit Pal Singh, Davinder Gill, Michael Lebens, Stefan Nordqvist, Jan Holmgren, John D. Clemens, Firdausi Qadri

    Research output: Contribution to journal › Article › peer-review

    6 Citations (Scopus)
    19 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'A phase I/II study to evaluate safety, tolerability and immunogenicity of Hillchol®, an inactivated single Hikojima strain based oral cholera vaccine, in a sequentially age descending population in Bangladesh'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science